Clinical Trial Update: Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Ocoxin-Viusid in metastatic colorectal adenocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colonic Diseases
• Colorectal Neoplasm
• Digestive System Disease
• Digestive System Neoplasm
• Gastrointestinal Disease
• Gastrointestinal Neoplasms
• Intestinal Disease
• Intestinal Neoplasms
• Rectal Diseases

Drugs mentioned

• Ocoxin®-Viusid®

Snippet

Sponsor: Catalysis SL | Conditions: Colorectal Neoplasm, Intestinal Neoplasms | Phase 2 | Status: COMPLETED